期刊文献+

采用稀释法评价狼疮抗凝物对凝血因子活性检测的干扰 被引量:2

Using dilution method to evaluate the interference of lupus anticoagulant in the detection of coagulation factor activity
下载PDF
导出
摘要 目的探讨稀释法在评价狼疮抗凝物(LAC)对凝血因子活性检测的干扰中的应用。方法选取该院健康体检者30例作为作为对照组,将这30例受试者的混合血浆标本分别按1∶1、1∶2^(1)、1∶2^(2)、1∶2^(3)、1∶2^(4)、1∶2^(5)6种不同稀释比例配制成不同浓度的血浆,检测标本中的凝血因子FⅧ、FⅨ、FⅪ、FⅫ、FⅡ、FⅤ、FⅦ、FⅩ活性,将其与所对应稀释度的理论值作线性相关分析。选取于该院住院治疗的LAC阳性且凝血酶原时间(PT)、活化的部分凝血活酶时间(APTT)均延长的抗磷脂综合征患者6例作为LAC阳性组。将6例LAC阳性组患者的血浆标本按同样的方法进行梯度稀释并对上述8种凝血因子的活性进行检测。结果对照组8种凝血因子活性检测值与理论值均呈直线相关(R^(2)≥0.90,P<0.05)。随着稀释倍数的增加,内源性凝血因子活性随之升高,能恢复到大致正常水平,且升高到一定水平时不再随着稀释倍数的增加而继续升高。结论病理性抗凝物质如LAC可对内源性凝血因子活性检测造成干扰,稀释法可通过降低干扰物质的滴度来获得更加准确的凝血因子检测值。 Objective To investigate the application value of dilution method in evaluating the interference of lupus anticoagulant(LAC)in the detection of coagulation factor activity.Methods A total of 30 healthy people in the hospital were enrolled as the control group,and the mixed plasma sample of the 30 healthy people were prepared into different concentrations of plasma according to 6 different dilution ratios 1∶1,1∶2^(1),1∶2^(2),1∶2^(3),1∶2^(4),1∶2^(5),detected the coagulation factors FⅧ,FⅨ,FⅪ,FⅫ,FⅡ,FⅤ,FⅦ,FⅩactivity in the plasma sample,and make a linear correlation analysis with the theoretical value of the corresponding dilution.Six patients with antiphospholipid syndrome who were hospitalized in the hospital with LAC positive and prolonged partial thromboplastin time(PT)and activated partial thromboplastin time(APTT)were enrolled as the LAC positive group.The plasma samples of the 6 patients in the LAC positive group were serially diluted in the same way and the activity of the above 8 coagulation factors were detected.Results In the control group,the detected activity values of the 8 coagulation factors were linearly correlated with the theoretical values(R^(2)≥0.90,P<0.05).As the dilution ratios increased,the endogenous coagulation factor activity increased and could return to roughly normal levels,and when it reached a certain level,it no longer continued to increase as the dilution factor increased.Conclusion Pathological anticoagulants such as LAC can interfere with the detection of endogenous coagulation factor activity.The dilution method can be used to obtain more accurate coagulation factor detection values by reducing the titer of interfering substances.
作者 颜楠 韩峰 刁艳君 陈启颖 刘家云 YAN Nan;HAN Feng;DIAO Yanjun;CHEN Qiying;LIU Jiayun(Department of Clinical Laboratory,Xijing Hospital Affiliated to Air Force Military Medical University,Xi′an,Shaanxi 710032,China)
出处 《检验医学与临床》 CAS 2021年第24期3588-3590,3594,共4页 Laboratory Medicine and Clinic
关键词 狼疮抗凝物 凝血因子活性 稀释曲线法 lupus anticoagulants coagulation factor activity dilution method
  • 相关文献

参考文献12

二级参考文献85

  • 1周振海,原耀光,李娟,李小银,罗绍凯,洪文德.获得性凝血因子抑制物的输血治疗[J].中国输血杂志,2004,17(4):259-260. 被引量:3
  • 2钟玉敏,朱铭,陈树宝,赵鑫.永存第五对主动脉弓[J].罕少疾病杂志,2000,7(1):1-2. 被引量:32
  • 3赵威.凝血因子平行稀释试验在筛选凝血因子Ⅷ抑制物中的应用[J].实用医学杂志,2006,22(2):217-218. 被引量:3
  • 4刘相东,李丽.系统性红斑狼疮发病机制的研究进展[J].滨州医学院学报,2007,30(3):210-212. 被引量:3
  • 5WOFHART M D, CARMEN G, INACULADA R E, et al. Epide miology of inhibitor development in haemophilia A patients treated with virusinactived plasma derived clotting factor concentration [J] . Vox Sang, 1999, 77(Suppl): 3.
  • 6中华人民共和国卫生部医政司.全国临床检验操作规程[M].3版.江苏:东南大学出版社,2010:59-62.
  • 7中华人民共和国卫生部.中国国家标准化委员会.全血及成分血质量要求(GBl8469-2012)[S].北京:中华人民共和国卫生部,2012:11-13.
  • 8中国合格评定国家认可委员会.检测和校准实验室能力认可准则(CNAS-CL01)[S].中国合格评定国家认可委员会,2005:25.
  • 9Huth-Kühne A,Baudo F,Collins P,et al.International recommendations on the diagnosis and treatment of patients with acquired hemophilia A[J].Haematologica,2009,94:566-575.
  • 10Mustonen P,Lehtonen K,Javela K,et al.Persistent antiphospholipid antibody(aPL)in asymptomatic carriers as a risk factor for future thrombotic events:a nationwide prospective study[J].Lupus,2014,23:1468-1476.

共引文献167

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部